Superior Planning, LLC’s Dr. Reddy's Laboratories RDY Stock Holding History

Superior Planning, LLC’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.45K	Buy	+115	New	+$1.42K	﹤0.01%	1666

Other funds holding RDY

Aikya Investment Management London, United Kingdom $337M AUM 15.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Superior Planning, LLC's RDY Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Dr. Reddy's Laboratories (RDY) in Q3 2026: 115 shares worth $1.45K. The stake represents ﹤0.01% of the portfolio and ranks #1666 among its holdings.

150 funds tracked by Wall St. Rank hold RDY as of Q3 2026.

Superior Planning, LLC held 115 shares of Dr. Reddy's Laboratories worth $1.45K as of Q3 2026.
Dr. Reddy's Laboratories was a new Superior Planning, LLC position in Q3 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1666 holding.
150 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.